Skip to main content

Table 2 Survival rates based on adjuvant therapies in LVSI-negative and LVSI-positive groups

From: The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer

Parameter

Survival period

LVSI-positive

LVSI-negative

p-value

No adjuvant therapy

3 years

90%

98.2%

0.044

5 years

80%

93.6%

0.025

Brachytherapy

3 years

93.3%

100%

0.013

5 years

77.4%

91.8%

0.037

Brachytherapy and EBRT

3 years

97.1%

100%

0.472

5 years

79.4%

92.1%

0.112